GlassScriptPhysician profile
Zaher Hakim
NPI 1306191853
$91,694.73
in general payments reported to CMS, 2019-2025
38 companies · $4,578 in 2025
The $4,578 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,684 · 2020: $5,640 · 2021: $8,860 · 2022: $6,127 · 2023: $31K · 2024: $30K · 2025: $4,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Food and Beverage: $8,800 · Travel and Lodging: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,800.00 |
| Food and Beverage | $8,799.55 |
| Travel and Lodging | $1,784.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $66,202.65 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $11,669.96 | 2019-2022 | |
| Penumbra, INC. | $2,176.23 | 2023-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $1,869.62 | 2019-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, General - Therapies |
| Abbott Laboratories | $1,705.78 | 2019-2024 | Perclose Proglide, Perclose Prostyle, Amplatzer |
| Stryker Corporation | $1,416.80 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $1,334.81 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,142.08 | 2019-2025 | Lifevest |
| Abiomed | $948.52 | 2019-2024 | Impella |
| Medtronic, INC. | $366.11 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Closurefast |
| Terumo Medical Corporation | $271.09 | 2022-2023 | Navicross, Glidewire |
| Pfizer INC. | $258.27 | 2019-2025 | |
| Astellas Pharma US INC | $216.10 | 2019 | |
| Amgen INC. | $213.24 | 2019-2025 | Repatha, Repatha |
| Bard Peripheral Vascular, INC. | $166.12 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaher Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.